Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% Lidocaine HCl Injection, USP, 50 mg/5mL vial; and 2% Lidocaine HCl Injection, USP, 100 mg/5mL vial to the user level. The recall was initiated d
Hospira, Inc., owned by drug major Pfizer Inc., is recalling certain Sodium Bicarbonate and Lidocaine HCl Injections citing the potential for presence of glass particulate matter, the U.